The 3-hydroxy-methylglutaryl coenzyme A lyase HCL1 is required for macrophage colonization by human fungal pathogen

Dervla T Isaac1, Alison Coady, Nancy Van Prooyen

  • 1Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.

Infection and Immunity
|November 28, 2012
PubMed

Insights

Histoplasma capsulatum uses HMG CoA lyase (HCL1) to survive within macrophages. Disabling HCL1 impairs fungal growth and survival, offering new insights into controlling this respiratory pathogen.

Area of Science:

  • Medical Mycology
  • Molecular Pathogenesis
  • Host-Pathogen Interactions

Background:

  • Histoplasma capsulatum is a fungal pathogen that infects macrophages.
  • Its survival mechanisms within the host cell, particularly phagolysosomal escape, are not fully understood.
  • Preventing phagolysosome acidification is a hypothesized virulence factor.

Purpose of the Study:

  • To identify genes essential for H. capsulatum virulence.
  • To investigate the role of 3-hydroxy-methylglutaryl coenzyme A (HMG CoA) lyase (HCL1) in H. capsulatum pathogenesis.
  • To determine if HCL1 is critical for intracellular survival and macrophage colonization.

Main Methods:

  • Screening for H. capsulatum mutants unable to lyse bone marrow-derived macrophages (BMDMs).
  • Characterizing an insertion mutant in the HCL1 gene.
  • Assessing mutant growth in BMDMs and in vitro.
  • Evaluating the impact of the hcl1 mutation on host survival in a murine infection model.

Main Results:

  • An HCL1 mutant was identified with impaired macrophage lysis and severe growth defects in BMDMs.
  • The hcl1 mutant failed to grow on leucine and acidified its growth medium.
  • Mutant-infected mice showed prolonged survival compared to wild-type infections.
  • The hcl1 mutant resided in acidified vacuoles within macrophages.

Conclusions:

  • HMG CoA lyase (HCL1) is crucial for H. capsulatum virulence and intracellular survival.
  • HCL1 function is essential for colonizing the macrophage phagosome, likely by managing leucine catabolism and pH.
  • Targeting HCL1 may represent a novel strategy for treating histoplasmosis.